Altered Myelin Lipid Homeostasis and Their Effect on Promyelinating Factor - PAK2 in PMP22 Haploinsufficiency

Phase 3 Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy and Safety Results in Patients with Generalized MG